Subscribe

Organon & Co. (OGN)

USD13.50 -0.02 (-0.15%)
US NYSE S&P 500 Healthcare Drug Manufacturers - General
Address 30 Hudson Street 7302
Jersey City, NJ, US
CEO Joseph T. Morrissey Jr.
Website organon.com
IPO 2021-05-14
CIK 1821825 ISIN US68622V1061

Explore sections of this company profile

Description

Organon & Co., a global pharmaceutical enterprise, is dedicated to developing and delivering a wide array of prescription therapies. Its women's health division features reproductive care products, encompassing birth control and fertility treatments, notably Nexplanon/Implanon, an extended-duration contraceptive. The company's biosimilars collection includes three immune-related medications (Brenzys, Renflexis, Hadlima) and two cancer therapies (Ontruzant, Aybintio). Additionally, Organon provides cardiovascular medications, such as cholesterol-reducing drugs (Zetia, Ezetrol, Vytorin, Inegy, Rosuzet, Zocor) and treatments for high blood pressure (Cozaar, Hyzaar). Their respiratory product line addresses asthma symptoms with brands like Singulair, Dulera, Zenhale, and Asmanex, and manages seasonal allergies through Singulair, Nasonex, Clarinex, and Aerius. Furthermore, their offerings extend to dermatological care (Diprosone, Elocon), bone strengthening (Fosamax), and non-narcotic pain relief (Arcoxia, Diprospan, Celestone). The portfolio also comprises Proscar for treating symptomatic benign prostatic hyperplasia and Propecia for combating male pattern hair loss. The company's products are primarily distributed to pharmaceutical wholesalers, retailers, medical facilities, government entities, and various managed healthcare organizations, including health maintenance organizations and pharmacy benefit managers. Organon & Co. was established in 2020 and is headquartered in Jersey City, New Jersey.

News Sentiment (7d)
78 Positive

Based on only 1 article — low confidence

Market Cap & Enterprise Value
Merger & Acquisition History

No mergers or acquisitions recorded for this company.

Index membership

IndexAddedRemovedStatus
S&P 500 2021-06-02 — Active
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary Loading…
Indicator 1D1W2W3W1M
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
Averages
Trend
Price
Levels
Draw
USD13.50 -0.02 (-0.15%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
8M
Beta
1.54
Float Shares
258.73M
Free Float %
98.5%
Price Performance
1D5D1M3M6M YTD1Y3Y5Y10YMax
+0.00% -0.30% +50.96% +88.81% +72.89% +85.91% +53.04% -36.13% -59.91% -59.91% -59.91%
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
vs.
Loading histogram data…

Revenue flow

Revenue by geography

Revenue by segment

From To

Revenue composition

From To

By product

By geography

Financial Statements

Income Statement

Balance Sheet

Cash Flow Statement

Key Metrics

Financial Ratios

Employees

Financial Growth (CAGR)

Market Data

Analyst Consensus (9 ratings, all time) Hold
Price Targets & DCF
Current price
13.50
Low 8.00 -40.7%
Consensus 11.33 -16.1%
Median 12.00 -11.1%
High 14.00 +3.7%
DCF (Unlevered) 28.44 +110.7%
DCF (Levered) 17.26 +27.8%

DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.

Ratings Trend (MoM) 0% Bullish
Rating 2026-05 Change
Strong Buy 0 -1
Buy 0 0
Hold 4 0
Sell 0 0
Strong Sell 1 -3
Price Target Summary
Period # Analysts Avg Target
Last Month 1
14.00
+3.7%
Last Quarter 3
11.33
-16.1%
Last Year 6
10.75
-20.4%
All Time 9
14.72
+9.0%
Quality scores
Altman Z-Score
894.83
Safe zone
Piotroski F-Score
7 / 9
Strong
MOAT Score
6 / 10
Developing
Composite Rating
B+
Overall Score
3 / 5
Medium
DCF Score
4 / 5
High
ROE Score
5 / 5
High
ROA Score
5 / 5
High
D/E Score
1 / 5
Low
P/E Score
3 / 5
Medium
P/Book Score
1 / 5
Low
Operational MOAT
✗ Below peers
  • ✗
    Revenue growth Drug Manufacturers - General: +6.6%
    -2.9% Q1'26: -3.5% (vs Q1'25)
  • ✗
    EPS growth Drug Manufacturers - General: +18.2%
    -78.4% Q1'26: +66.7% (vs Q1'25)
  • ✓
    FCF margin FCF growth · Drug Manufacturers - General: +36.0%
    +2.1% Q1'26: +12.9% (vs Q1'25)
  • ✗
    EBIT margin Drug Manufacturers - General: +19.4%
    +15.0% Q1'26: +18.2% (vs Q1'25)
  • ✗
    ROIC Drug Manufacturers - General: +10.2%
    +6.2% Q1'26: +8,728.0% (vs Q1'25)
  • ✗
    Share dilution Drug Manufacturers - General: +0.0%
    +0.6% Q1'26: +0.7% (vs Q1'25)
  • ✗
    Debt / EBITDA Net debt/EBITDA · Drug Manufacturers - General: -0.29×
    6.86× Q1'26: 0.01× (vs Q1'25)
Valuation Multiples From To
Price Forecast (3Y) From To
Model
Adjust
P/E
Theoretical Return — If Invested Today

* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.

DCF Interactive Model (UFCF)
Projection years:
Market assumptions
▶ WACC components (optional)
Ke (Cost of Equity) = Rf + β (1.55) × ERP
WACC = 28% × Ke + 72% × Kd (5.7%) × (1−t)

Modifying these values recalculates WACC automatically.

Business assumptions
—
Intrinsic value (base): 28.44 Current price: 13.50
Enterprise Value: — Equity Value: — Terminal Value: — TV as % of EV: —

Base values reflect the latest available data for this company and market conditions.

Consensus Estimates
Metric Dec 2021
actual 		Dec 2022
actual 		Dec 2023
actual 		Dec 2024
actual 		Dec 2025
actual 		Dec 2026
5 Rev. Ana.
4 EPS Ana. 		Dec 2027
5 Rev. Ana.
4 EPS Ana. 		Dec 2028
5 Rev. Ana.
1 EPS Ana. 		Dec 2029
2 Rev. Ana.
1 EPS Ana. 		Dec 2030
2 Rev. Ana.
1 EPS Ana.
Revenue
6.30B
est: 6.27B (+0.5%)
6.17B
est: 6.18B (-0.2%)
6.26B
est: 6.35B (-1.3%)
6.40B
est: 6.41B (-0.1%)
6.22B
est: 6.22B (-0.1%)
6.13B
6.02B – 6.19B
-1.5% YoY
6.23B
6.08B – 6.33B
+1.6% YoY
6.27B
6.11B – 6.38B
+0.6% YoY
6.46B
6.30B – 6.58B
+3.1% YoY
6.51B
6.34B – 6.62B
+0.7% YoY
EBITDA
1.98B
est: 1.93B (+2.8%)
1.76B
est: 1.72B (+1.9%)
1.44B
est: 1.63B (-11.9%)
1.60B
est: 1.65B (-2.6%)
1.28B
est: 1.60B (-19.8%)
1.58B
1.55B – 1.59B
-1.5% YoY
1.60B
1.56B – 1.63B
+1.6% YoY
1.61B
1.57B – 1.64B
+0.6% YoY
1.66B
1.62B – 1.69B
+3.1% YoY
1.67B
1.63B – 1.70B
+0.7% YoY
EBIT
1.79B
est: 1.72B (+4.1%)
1.54B
est: 1.40B (+10.6%)
1.20B
est: 1.37B (-12.6%)
1.33B
est: 1.39B (-4.3%)
929.00M
est: 1.35B (-31.0%)
1.33B
1.30B – 1.34B
-1.5% YoY
1.35B
1.31B – 1.37B
+1.6% YoY
1.36B
1.32B – 1.38B
+0.6% YoY
1.40B
1.36B – 1.42B
+3.1% YoY
1.41B
1.37B – 1.43B
+0.7% YoY
Net Income
1.35B
est: 1.63B (-17.0%)
917.00M
est: 969.57M (-5.4%)
1.02B
est: 1.00B (+2.3%)
864.00M
est: 1.07B (-19.5%)
187.00M
est: 973.68M (-80.8%)
897.57M
878.93M – 916.22M
-7.8% YoY
953.45M
901.88M – 1.01B
+6.2% YoY
997.69M
969.40M – 1.03B
+4.6% YoY
990.90M
958.15M – 1.01B
-0.7% YoY
1.02B
983.36M – 1.04B
+2.6% YoY
SGA
1.67B
est: 1.66B (+0.3%)
1.70B
est: 1.50B (+13.7%)
1.89B
est: 1.77B (+7.1%)
1.76B
est: 1.78B (-1.4%)
1.71B
est: 1.73B (-1.3%)
1.71B
1.68B – 1.73B
-1.5% YoY
1.74B
1.69B – 1.76B
+1.6% YoY
1.75B
1.70B – 1.78B
+0.6% YoY
1.80B
1.75B – 1.83B
+3.1% YoY
1.81B
1.77B – 1.84B
+0.7% YoY
EPS
5.33
est: 6.28 (-15.2%)
3.61
est: 4.98 (-27.5%)
4.01
est: 3.91 (+2.7%)
3.36
est: 4.11 (-18.2%)
0.72
est: 3.75 (-80.8%)
3.44
3.37 – 3.51
-8.3% YoY
3.66
3.46 – 3.85
+6.4% YoY
3.84
3.72 – 3.93
+5.0% YoY
3.80
3.67 – 3.89
-1.2% YoY
3.90
3.77 – 3.99
+2.6% YoY
Recent Grade Changes (3M)
Date Firm Previous New Grade Action
2026-04-29 BNP Paribas Outperform Neutral Downgrade
2026-04-28 Piper Sandler Underweight Neutral Upgrade
Historical Ratings (3M)
Date Rating Overall DCF ROE ROA D/E P/E P/B
2026-05-11 B+ 3/5 4/5 5/5 5/5 1/5 3/5 1/5
2026-05-08 A- 4/5 4/5 5/5 5/5 1/5 4/5 1/5
2026-05-07 A- 4/5 4/5 5/5 5/5 1/5 4/5 1/5
2026-05-06 A- 4/5 5/5 5/5 5/5 1/5 4/5 1/5
2026-05-05 A- 4/5 5/5 5/5 5/5 1/5 4/5 1/5
2026-05-04 A- 4/5 5/5 5/5 5/5 1/5 4/5 1/5
2026-05-01 A 4/5 5/5 5/5 4/5 1/5 4/5 3/5
2026-04-30 A 4/5 5/5 5/5 4/5 1/5 4/5 3/5
2026-04-29 A 4/5 5/5 5/5 4/5 1/5 4/5 3/5
2026-04-28 A 4/5 5/5 5/5 4/5 1/5 4/5 3/5
2026-04-27 A 4/5 5/5 5/5 4/5 1/5 4/5 3/5
2026-04-24 A- 4/5 5/5 5/5 4/5 1/5 3/5 3/5
2026-04-23 A- 4/5 5/5 5/5 4/5 1/5 3/5 3/5
2026-04-22 A- 4/5 5/5 5/5 4/5 1/5 3/5 3/5
2026-04-21 A- 4/5 5/5 5/5 4/5 1/5 3/5 3/5
2026-04-20 A- 4/5 5/5 5/5 4/5 1/5 3/5 3/5
2026-04-17 A- 4/5 5/5 5/5 4/5 1/5 3/5 3/5
2026-04-16 A- 4/5 5/5 5/5 4/5 1/5 3/5 3/5
2026-04-15 A- 4/5 5/5 5/5 4/5 1/5 3/5 3/5

Owner Earnings

Owner's Earnings (history) From To
Owner alignment
Owner's Earnings TTM
375.77M
OE per share TTM
1.44
Owner's Yield
10.83%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
15.1%

Ownership Overview

Ownership breakdown
At a glance
Institutional holders
217
Total invested
31.54M
Insider transactions (90d)
0
Beneficial owners (>5%)
3
Beneficial owners (>5%)
# Reporting person ⇅ Amount owned ⇅ % of class ⇅ Sole voting ⇅ Shared voting ⇅ Sole dispositive ⇅ Shared dispositive ⇅ Type Citizenship Filing date ⇅ SEC filing
1 The Vanguard Group - 23-1945930 28.77M 11.35% — 346.2K 27.74M 1.04M IA Pennsylvania For 2022-02-10 ↗
2 (1) BlackRock, Inc. 16.90M 6.70% 14.59M — 16.90M — HC Delaware 2022-02-04 ↗
3 STATE STREET CORPORATION 12.86M 5.06% — 11.99M — 12.86M HC BOSTON, MASSACHUSETTS 2023-02-10 ↗

Institutional Activity (13F)

Institutional ownership trend From To
13F snapshot — 2026 Q1
Investors holding
217
-424 vs prev Q
New positions
16
Closed positions
420
Increased
51
Reduced
76
Put/Call ratio
0.00
Calls held
7.0K
Puts held
—
Top institutional holders
# Investor ⇅ Shares / Δ ⇅ Mkt value / Δ ⇅ Own% / Δ ⇅ Weight% / Δ ⇅ Avg px / Perf. ⇅ Hold / Status ⇅
1 — 187.5K +187.5K (+100.0%) 1.34B +1.3B (+100.0%) 0.07% +0.072 pp 0.53% +0.531 pp USD7.17 +0.0% 1 qtrs NEW
2 VANGUARD GROUP INC 36.92M +988.0K (+2.7%) 264.69M -119.0M (-31.0%) 14.19% +0.367 pp 0.00% -0.002 pp USD26.01 -72.4% 19 qtrs —
3 BLACKROCK, INC. 30.97M +107.3K (+0.3%) 222.03M -107.5M (-32.6%) 11.90% +0.031 pp 0.00% -0.002 pp USD19.01 -62.3% 6 qtrs —
4 STATE STREET CORP 9.60M +262.2K (+2.8%) 68.82M -30.9M (-31.0%) 3.69% +0.098 pp 0.00% -0.001 pp USD28.32 -74.7% 19 qtrs —
5 AQR CAPITAL MANAGEMENT LLC 8.57M +4.4M (+105.2%) 61.28M +17.6M (+40.4%) 3.30% +1.690 pp 0.03% +0.004 pp USD10.70 -33.0% 19 qtrs —
6 LSV ASSET MANAGEMENT 7.47M -362.1K (-4.6%) 53.58M -30.1M (-36.0%) 2.87% -0.142 pp 0.12% -0.068 pp USD22.26 -67.8% 19 qtrs —
7 MASSACHUSETTS FINANCIAL SERVICES CO /MA/ 6.88M -2.6M (-27.6%) 49.35M -52.1M (-51.4%) 2.65% -1.008 pp 0.02% -0.016 pp USD26.78 -73.2% 19 qtrs —
8 GEODE CAPITAL MANAGEMENT, LLC 4.60M -215.1K (-4.5%) 32.99M -18.4M (-35.9%) 1.77% -0.084 pp 0.00% -0.001 pp USD26.08 -72.5% 19 qtrs —
9 PRIVATE MANAGEMENT GROUP INC 4.35M +1.2M (+38.3%) 31.17M -2.4M (-7.1%) 1.67% +0.463 pp 0.91% -0.092 pp USD14.78 -51.5% 19 qtrs —
10 UBS GROUP AG 4.30M +1.5M (+55.2%) 30.80M +1.2M (+4.2%) 1.65% +0.586 pp 0.01% +0.000 pp USD9.98 -28.2% 19 qtrs —
11 KAHN BROTHERS GROUP INC 3.63M +12.6K (+0.3%) 26.02M -12.6M (-32.6%) 1.40% +0.005 pp 4.61% -2.655 pp USD15.17 -52.7% 19 qtrs —
12 SIO CAPITAL MANAGEMENT, LLC 3.42M +3.4M (+100.0%) 24.53M +24.5M (+100.0%) 1.32% +1.315 pp 3.86% +3.859 pp USD7.17 +0.0% 1 qtrs NEW
13 D. E. SHAW & CO., INC. 3.39M +2.9M (+590.0%) 24.28M +19.0M (+363.2%) 1.30% +1.114 pp 0.01% +0.010 pp USD7.68 -6.6% 2 qtrs —
14 DIMENSIONAL FUND ADVISORS LP 3.38M -305.4K (-8.3%) 24.26M -15.1M (-38.4%) 1.30% -0.118 pp 0.01% -0.003 pp USD19.95 -64.1% 19 qtrs —
15 MORGAN STANLEY 3.18M -1.2M (-27.0%) 22.79M -23.7M (-51.0%) 1.22% -0.455 pp 0.00% -0.002 pp USD20.67 -65.3% 19 qtrs —
16 CHARLES SCHWAB INVESTMENT MANAGEMENT INC 2.91M -203.8K (-6.6%) 20.84M -12.4M (-37.3%) 1.12% -0.079 pp 0.00% -0.002 pp USD24.20 -70.4% 19 qtrs —
17 GOTHAM ASSET MANAGEMENT, LLC 2.65M -1.1M (-28.5%) 19.03M -20.6M (-52.0%) 1.02% -0.409 pp 0.07% -0.103 pp USD12.73 -43.7% 19 qtrs —
18 CANADA PENSION PLAN INVESTMENT BOARD 2.43M +56.2K (+2.4%) 17.42M -7.9M (-31.3%) 0.93% +0.021 pp 0.01% -0.006 pp USD10.64 -32.6% 19 qtrs —
19 BANK OF NEW YORK MELLON CORP 2.26M -1.3M (-36.7%) 16.21M -21.9M (-57.5%) 0.87% -0.505 pp 0.00% -0.005 pp USD25.45 -71.8% 19 qtrs —
20 INVESCO LTD. 2.22M +613.4K (+38.1%) 15.93M -1.2M (-7.3%) 0.85% +0.235 pp 0.00% 0.000 pp USD16.91 -57.6% 19 qtrs —
21 TWO SIGMA INVESTMENTS, LP 2.17M +1.5M (+238.4%) 15.56M +8.7M (+127.2%) 0.83% +0.588 pp 0.02% +0.012 pp USD8.14 -11.9% 3 qtrs —
22 CITADEL ADVISORS LLC 2.06M +1.6M (+395.6%) 14.79M +10.3M (+232.7%) 0.79% +0.633 pp 0.00% +0.002 pp USD8.45 -15.1% 19 qtrs —
23 JANE STREET GROUP, LLC 2.01M +1.7M (+573.6%) 14.39M +11.2M (+352.2%) 0.77% +0.658 pp 0.00% +0.002 pp USD8.69 -17.5% 19 qtrs —
24 GOLDMAN SACHS GROUP INC 1.88M +224.0K (+13.5%) 13.48M -4.2M (-23.8%) 0.72% +0.086 pp 0.00% -0.001 pp USD14.70 -51.2% 19 qtrs —
25 NORTHERN TRUST CORP 1.82M -119.5K (-6.2%) 13.05M -7.7M (-37.0%) 0.70% -0.046 pp 0.00% -0.001 pp USD26.14 -72.6% 19 qtrs —
26 FIRST TRUST ADVISORS LP 1.81M -353.0K (-16.3%) 12.99M -10.1M (-43.8%) 0.70% -0.136 pp 0.01% -0.008 pp USD19.30 -62.8% 17 qtrs —
27 BANK OF AMERICA CORP /DE/ 1.78M +1.3M (+242.0%) 12.76M +7.2M (+129.6%) 0.68% +0.484 pp 0.00% +0.001 pp USD11.71 -38.8% 19 qtrs —
28 TWO SIGMA ADVISERS, LP 1.74M +1.2M (+198.8%) 12.45M +6.2M (+100.6%) 0.67% +0.444 pp 0.02% +0.012 pp USD8.12 -11.7% 3 qtrs —
29 WALLEYE CAPITAL LLC 1.49M +1.4M (+2,730.6%) 10.65M +10.1M (+1,800.3%) 0.57% +0.551 pp 0.03% +0.031 pp USD7.29 -1.6% 12 qtrs —
30 PARALLAX VOLATILITY ADVISERS, L.P. 1.41M +207.9K (+17.3%) 10.09M -2.7M (-21.2%) 0.54% +0.080 pp 0.02% +0.001 pp USD10.16 -29.4% 2 qtrs —
31 PRINCIPAL FINANCIAL GROUP INC 1.24M -11.9K (-1.0%) 8.86M -4.5M (-33.5%) 0.48% -0.005 pp 0.00% -0.002 pp USD22.86 -68.6% 19 qtrs —
32 MITSUBISHI UFJ TRUST & BANKING CORP 1.23M -202.4K (-14.1%) 8.81M -6.5M (-42.4%) 0.47% -0.078 pp 0.02% -0.013 pp USD13.90 -48.4% 19 qtrs —
33 ALLIANZ ASSET MANAGEMENT GMBH 1.17M -116.4K (-9.0%) 8.42M -5.4M (-38.9%) 0.45% -0.045 pp 0.01% -0.007 pp USD17.95 -60.1% 19 qtrs —
34 CERITY PARTNERS LLC 1.09M -562.1K (-34.0%) 7.83M -9.8M (-55.7%) 0.42% -0.216 pp 0.01% -0.017 pp USD14.41 -50.2% 9 qtrs —
35 M&G PLC 992.3K +49.5K (+5.2%) 6.95M -3.4M (-33.0%) 0.38% +0.019 pp 0.04% -0.020 pp USD12.38 -42.1% 8 qtrs —
36 WELLS FARGO & COMPANY/MN 910.9K +558.1K (+158.2%) 6.53M +2.8M (+73.3%) 0.35% +0.214 pp 0.00% +0.001 pp USD12.42 -42.3% 19 qtrs —
37 BRIDGEWATER ASSOCIATES, LP 909.2K +240.5K (+36.0%) 6.52M -622.4K (-8.7%) 0.35% +0.092 pp 0.02% -0.004 pp USD10.02 -28.4% 6 qtrs —
38 PUBLIC SECTOR PENSION INVESTMENT BOARD 901.0K -113.0K (-11.1%) 6.46M -4.4M (-40.3%) 0.35% -0.044 pp 0.02% -0.018 pp USD14.37 -50.1% 19 qtrs —
39 UBS ASSET MANAGEMENT AMERICAS INC 803.6K +6.6K (+0.8%) 5.76M -2.8M (-32.3%) 0.31% +0.003 pp 0.00% -0.001 pp USD21.82 -67.1% 19 qtrs —
40 LEGAL & GENERAL GROUP PLC 779.8K -32.1K (-4.0%) 5.59M -3.1M (-35.5%) 0.30% -0.012 pp 0.00% -0.001 pp USD27.41 -73.8% 19 qtrs —
41 SUSQUEHANNA INTERNATIONAL GROUP, LLP 690.7K +161.1K (+30.4%) 4.95M -703.8K (-12.4%) 0.27% +0.062 pp 0.00% 0.000 pp USD13.30 -46.1% 19 qtrs —
42 BEDDOW CAPITAL MANAGEMENT INC 666.7K +15.9K (+2.4%) 4.78M -2.2M (-31.2%) 0.26% +0.006 pp 1.80% -0.757 pp USD15.50 -53.7% 19 qtrs —
43 POINT72 ASSET MANAGEMENT, L.P. 655.7K +655.7K (+100.0%) 4.70M +4.7M (+100.0%) 0.25% +0.252 pp 0.01% +0.005 pp USD7.17 +0.0% 1 qtrs NEW
44 AMERIPRISE FINANCIAL INC 630.8K +46.2K (+7.9%) 4.52M -1.7M (-27.6%) 0.24% +0.018 pp 0.00% 0.000 pp USD16.73 -57.1% 19 qtrs —
45 BRANDES INVESTMENT PARTNERS, LP 606.5K +193.1K (+46.7%) 4.35M -66.9K (-1.5%) 0.23% +0.074 pp 0.03% -0.002 pp USD10.94 -34.5% 9 qtrs —
46 AMERICAN CENTURY COMPANIES INC 606.4K +13.4K (+2.3%) 4.35M -2.0M (-31.3%) 0.23% +0.005 pp 0.00% -0.001 pp USD10.66 -32.7% 18 qtrs —
47 NATIXIS 546.6K +546.5K (+958,835.1%) 3.92M +3.9M (+643,425.8%) 0.21% +0.210 pp 0.01% +0.014 pp USD7.17 +0.0% 2 qtrs —
48 UNIVERSAL- BETEILIGUNGS- UND SERVICEGESELLSCHAFT MBH 525.4K +111.9K (+27.1%) 3.77M -648.7K (-14.7%) 0.20% +0.043 pp 0.01% -0.001 pp USD13.27 -46.0% 5 qtrs —
49 READYSTATE ASSET MANAGEMENT LP 514.8K -386.9K (-42.9%) 3.69M -5.9M (-61.7%) 0.20% -0.149 pp 0.15% -0.261 pp USD12.42 -42.3% 10 qtrs —
50 VICTORY CAPITAL MANAGEMENT INC 514.0K +54.5K (+11.9%) 3.69M -1.2M (-24.9%) 0.20% +0.021 pp 0.00% -0.001 pp USD16.43 -56.4% 19 qtrs —
51 SWISS NATIONAL BANK 512.6K +8.4K (+1.7%) 3.68M -1.7M (-31.7%) 0.20% +0.003 pp 0.00% -0.001 pp USD29.30 -75.5% 19 qtrs —
52 CITIGROUP INC 506.1K +285.6K (+129.5%) 3.63M +1.3M (+54.1%) 0.19% +0.110 pp 0.00% +0.001 pp USD12.06 -40.5% 19 qtrs —
53 VOLORIDGE INVESTMENT MANAGEMENT, LLC 498.6K -3.3K (-0.7%) 3.58M -1.8M (-33.3%) 0.19% -0.002 pp 0.01% -0.005 pp USD10.34 -30.7% 8 qtrs —
54 FRANKLIN RESOURCES INC 497.9K +83.3K (+20.1%) 3.57M -858.0K (-19.4%) 0.19% +0.032 pp 0.00% 0.000 pp USD16.58 -56.8% 19 qtrs —
55 DOUGLAS LANE & ASSOCIATES, LLC 485.7K +41.9K (+9.4%) 3.48M -1.3M (-26.5%) 0.19% +0.016 pp 0.05% -0.019 pp USD17.60 -59.3% 19 qtrs —
56 RHUMBLINE ADVISERS 470.6K +1.8K (+0.4%) 3.37M -1.6M (-32.6%) 0.18% +0.001 pp 0.00% -0.001 pp USD26.50 -72.9% 19 qtrs —
57 MILLENNIUM MANAGEMENT LLC 460.9K -4.1M (-89.8%) 3.30M -45.0M (-93.2%) 0.18% -1.565 pp 0.00% -0.019 pp USD10.25 -30.0% 19 qtrs —
58 GRANTHAM, MAYO, VAN OTTERLOO & CO. LLC 447.7K -46.4K (-9.4%) 3.21M -2.1M (-39.2%) 0.17% -0.018 pp 0.01% -0.007 pp USD13.81 -48.1% 9 qtrs —
59 MARSHALL WACE, LLP 440.0K +365.1K (+487.9%) 3.15M +2.4M (+294.7%) 0.17% +0.140 pp 0.00% +0.002 pp USD7.60 -5.7% 6 qtrs —
60 NUVEEN, LLC 436.0K -124.5K (-22.2%) 3.13M -2.9M (-47.8%) 0.17% -0.048 pp 0.00% -0.001 pp USD14.78 -51.5% 4 qtrs —
61 Y-INTERCEPT (HONG KONG) LTD 406.2K +218.9K (+116.9%) 2.91M +912.3K (+45.6%) 0.16% +0.084 pp 0.07% +0.017 pp USD8.79 -18.4% 2 qtrs —
62 ADVISORS ASSET MANAGEMENT, INC. 388.5K -131.3K (-25.3%) 2.79M -2.8M (-49.8%) 0.15% -0.051 pp 0.05% -0.048 pp USD20.40 -64.9% 19 qtrs —
63 QUANTINNO CAPITAL MANAGEMENT LP 363.5K +218.9K (+151.4%) 2.61M +1.1M (+68.8%) 0.14% +0.084 pp 0.01% +0.001 pp USD9.58 -25.2% 7 qtrs —
64 SQUAREPOINT OPS LLC 360.9K +85.3K (+30.9%) 2.59M -356.3K (-12.1%) 0.14% +0.033 pp 0.00% 0.000 pp USD9.53 -24.8% 19 qtrs —
65 BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. 335.6K +332.7K (+11,497.7%) 2.41M +2.4M (+7,661.3%) 0.13% +0.128 pp 0.00% +0.003 pp USD7.19 -0.3% 3 qtrs —
66 NOMURA HOLDINGS INC 317.9K +317.9K (+100.0%) 2.28M +2.3M (+100.0%) 0.12% +0.122 pp 0.00% +0.003 pp USD7.17 +0.0% 1 qtrs NEW
67 SECTOR GAMMA AS 300.0K -243.7K (-44.8%) 2.15M -3.7M (-63.0%) 0.12% -0.094 pp 0.49% -0.950 pp USD10.68 -32.9% 2 qtrs —
68 NEW YORK STATE TEACHERS RETIREMENT SYSTEM 284.4K -2.6K (-0.9%) 2.04M -1.0M (-33.5%) 0.11% -0.001 pp 0.00% -0.002 pp USD27.38 -73.8% 19 qtrs —
69 JPMORGAN CHASE & CO 279.6K -40.8K (-12.7%) 2.00M -1.4M (-41.4%) 0.11% -0.016 pp 0.00% 0.000 pp USD25.59 -72.0% 19 qtrs —
70 STATE OF ALASKA, DEPARTMENT OF REVENUE 278.4K +1.6K (+0.6%) 2.00M -961.0K (-32.5%) 0.11% +0.001 pp 0.02% -0.009 pp USD13.24 -45.8% 19 qtrs —
71 SG AMERICAS SECURITIES, LLC 276.1K +118.0K (+74.6%) 1.98M +291.0K (+17.2%) 0.11% +0.045 pp 0.00% -0.003 pp USD9.94 -27.9% 19 qtrs —
72 ROYAL BANK OF CANADA 276.2K -11.6K (-4.0%) 1.98M -1.1M (-35.6%) 0.11% -0.005 pp 0.00% 0.000 pp USD18.19 -60.6% 19 qtrs —
73 PRUDENTIAL FINANCIAL INC 274.4K -11.1K (-3.9%) 1.97M -664.8K (-25.3%) 0.11% -0.004 pp 0.00% -0.001 pp USD20.71 -65.4% 19 qtrs —
74 NORGES BANK 264.9K +264.9K (+100.0%) 1.90M +1.9M (+100.0%) 0.10% +0.102 pp 0.00% +0.000 pp USD7.17 +0.0% 1 qtrs NEW
75 XTX TOPCO LTD 261.3K +146.0K (+126.6%) 1.87M +642.2K (+52.2%) 0.10% +0.056 pp 0.05% -0.015 pp USD8.68 -17.4% 7 qtrs —
76 CAPITAL FUND MANAGEMENT S.A. 259.0K -201.6K (-43.8%) 1.86M -3.1M (-62.2%) 0.10% -0.078 pp 0.01% -0.008 pp USD13.85 -48.2% 11 qtrs —
77 RAYMOND JAMES FINANCIAL INC 258.0K -62.5K (-19.5%) 1.85M -1.6M (-46.0%) 0.10% -0.024 pp 0.00% -0.001 pp USD13.68 -47.6% 5 qtrs —
78 TWINBEECH CAPITAL LP 258.0K -12.1K (-4.5%) 1.85M -1.0M (-35.9%) 0.10% -0.005 pp 0.13% +0.017 pp USD14.00 -48.8% 11 qtrs —
79 VIRGINIA RETIREMENT SYSTEMS ET AL 254.5K +232.6K (+1,062.1%) 1.82M +1.6M (+680.2%) 0.10% +0.090 pp 0.01% +0.009 pp USD7.39 -3.0% 3 qtrs —
80 CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM 242.6K -7.6K (-3.0%) 1.74M -932.8K (-34.9%) 0.09% -0.003 pp 0.00% -0.001 pp USD29.16 -75.4% 19 qtrs —
81 STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM 230.4K -7.7K (-3.2%) 1.65M -890.8K (-35.0%) 0.09% -0.003 pp 0.00% -0.002 pp USD29.82 -76.0% 19 qtrs —
82 PHILIP JAMES WEALTH MANGEMENT, LLC 229.2K -214.9K (-48.4%) 1.64M -3.1M (-65.4%) 0.09% -0.083 pp 0.19% -0.363 pp USD18.74 -61.7% 6 qtrs —
83 VERITION FUND MANAGEMENT LLC 222.0K +209.8K (+1,720.8%) 1.59M +1.5M (+1,122.4%) 0.09% +0.081 pp 0.01% +0.006 pp USD7.60 -5.7% 6 qtrs —
84 PDT PARTNERS, LLC 221.6K +221.6K (+100.0%) 1.59M +1.6M (+100.0%) 0.09% +0.085 pp 0.10% +0.103 pp USD7.17 +0.0% 1 qtrs NEW
85 BREVAN HOWARD CAPITAL MANAGEMENT LP 217.0K +160.4K (+283.4%) 1.56M +951.5K (+157.4%) 0.08% +0.062 pp 0.02% +0.014 pp USD8.44 -15.0% 5 qtrs —
86 POEHLING CAPITAL MANAGEMENT, INC. 216.5K -101.3K (-31.9%) 1.55M -1.8M (-54.3%) 0.08% -0.039 pp 0.32% -0.396 pp USD13.08 -45.2% 9 qtrs —
87 CM MANAGEMENT, LLC 200.0K -25.0K (-11.1%) 1.43M -969.0K (-40.3%) 0.08% -0.010 pp 1.21% -0.795 pp USD13.29 -46.0% 13 qtrs —
88 VAN ECK ASSOCIATES CORP 196.4K +104.4K (+113.5%) 1.41M +425.0K (+43.2%) 0.08% +0.040 pp 0.00% +0.000 pp USD12.54 -42.8% 19 qtrs —
89 STIFEL FINANCIAL CORP 194.3K -19.4K (-9.1%) 1.39M -889.3K (-39.0%) 0.07% -0.008 pp 0.00% -0.001 pp USD22.38 -68.0% 19 qtrs —
90 HOWARD CAPITAL MANAGEMENT INC. 178.9K +— (+0.0%) 1.28M -628.0K (-32.9%) 0.07% +0.000 pp 0.02% -0.009 pp USD19.13 -62.5% 6 qtrs —
91 THRIVENT FINANCIAL FOR LUTHERANS 178.6K -68.9K (-27.8%) 1.28M -1.4M (-51.6%) 0.07% -0.027 pp 0.00% -0.003 pp USD12.97 -44.7% 19 qtrs —
92 MOORE CAPITAL MANAGEMENT, LP 177.4K +177.4K (+100.0%) 1.27M +1.3M (+100.0%) 0.07% +0.068 pp 0.02% +0.018 pp USD7.17 +0.0% 1 qtrs NEW
Ownership breakdown by holder

Insider Activity

Insider Activity — Latest Quarter
Ratio by transactions
0.77
Neutral
Ratio by volume
3.00
Bullish
Buys
53
Sells
69
Shares acquired
2.42M
Shares disposed
429.6K
Cash buys
—
Cash sales
—
Net activity
+1,987,036
Insider buys vs sells (history) From To
Recent insider transactions From To
Date Person Role Transaction A/D Security Shares Price Value Owned after D/I Filing
2026-03-31 Weaver Kirke Officer F-InKind D Common Stock 1,767 5.70 10.1K 83,835 D ↗
2026-03-31 WALSH MATTHEW M Officer A-Award A Restricted Stock Units 321,368 0.00 — 321,368 D ↗
2026-03-31 Stahler Rachel A Officer A-Award A Restricted Stock Units 183,639 0.00 — 183,639 D ↗
2026-03-31 Nisita Vittorio Officer M-Exempt A Common Stock 4,606 0.00 — 66,678 D ↗
2026-03-31 Morrissey Joseph T. Jr. Officer F-InKind D Common Stock 4,784 5.70 27.3K 123,123 D ↗
2026-03-31 Karp Daniel Officer F-InKind D Common Stock 3,554 5.70 20.3K 64,938 D ↗
2026-03-31 Holzbaur Lynette Officer — — Restricted Stock Units 20,147 0.00 — 0 D ↗
2026-03-31 Falcione Aaron Officer M-Exempt D Restricted Stock Units 6,732 0.00 — 0 D ↗
2026-03-31 Drinane Juliana Papa Officer A-Award A Restricted Stock Units 125,208 0.00 — 125,208 D ↗
2026-03-31 Arjona Ferreira Juan Camilo Officer M-Exempt A Common Stock 13,431 0.00 — 34,867 D ↗
2026-03-29 Weaver Kirke Officer F-InKind D Common Stock 2,210 5.84 12.9K 79,401 D ↗
2026-03-29 WALSH MATTHEW M Officer M-Exempt D Restricted Stock Units 15,071 0.00 — 15,071 D ↗
2026-03-29 Stahler Rachel A Officer M-Exempt A Common Stock 8,200 0.00 — 106,510 D ↗
2026-03-29 Nisita Vittorio Officer M-Exempt D Restricted Stock Units 5,762 0.00 — 5,763 D ↗
2026-03-29 Morrissey Joseph T. Jr. Officer M-Exempt A Common Stock 9,752 0.00 — 108,323 D ↗
2026-03-29 Karp Daniel Officer F-InKind D Common Stock 4,446 5.84 26.0K 57,154 D ↗
2026-03-29 Holzbaur Lynette Officer F-InKind D Common Stock 1,516 5.84 8.9K 18,561 D ↗
2026-03-29 Falcione Aaron Officer M-Exempt D Restricted Stock Units 8,422 0.00 — 8,422 D ↗
2026-03-29 Drinane Juliana Papa Officer F-InKind D Common Stock 2,733 5.84 16.0K 22,421 D ↗
2026-03-29 Arjona Ferreira Juan Camilo Officer M-Exempt A Common Stock 8,865 0.00 — 23,909 D ↗
2026-02-27 Weaver Kirke Officer F-InKind D Common Stock 6,815 7.17 48.9K 67,599 D ↗
2026-02-27 WALSH MATTHEW M Officer A-Award A Common Stock 12,020 0.00 — 184,216 D ↗
2026-02-27 Stahler Rachel A Officer F-InKind D Common Stock 8,475 7.17 60.8K 91,934 D ↗
2026-02-27 Nisita Vittorio Officer A-Award A Common Stock 4,596 0.00 — 58,495 D ↗
2026-02-27 Morrissey Joseph T. Jr. Officer F-InKind D Common Stock 2,216 7.23 16.0K 98,571 D ↗
2026-02-27 Falcione Aaron Officer A-Award A Common Stock 23,805 0.00 — 86,779 D ↗
2025-11-13 Morrissey Joseph T. Jr. Officer A-Award A Restricted Stock Units 131,233 0.00 — 131,233 D ↗
2025-11-13 Drinane Juliana Papa Officer A-Award A Restricted Stock Units 65,616 0.00 — 65,616 D ↗
2025-11-12 COX CARRIE SMITH Director / Officer P-Purchase A Common Stock 65,400 7.67 501.8K 77,869 I ↗
2025-11-07 Holzbaur Lynette Officer M-Exempt D Restricted Stock Units 2,417 0.00 — 2,418 D ↗
2025-11-07 Drinane Juliana Papa Officer M-Exempt A Restricted Stock Units 3,626 0.00 — 3,626 D ↗
2025-11-07 Arjona Ferreira Juan Camilo Officer M-Exempt A Common Stock 6,446 0.00 — 31,223 D ↗
2025-11-05 Holzbaur Lynette Officer M-Exempt A Common Stock 3,037 0.00 — 13,814 D ↗
2025-10-27 Drinane Juliana Papa Officer — — Common Stock 0 0.00 — 14,791 D ↗
2025-08-11 Arjona Ferreira Juan Camilo Officer F-InKind D Common Stock 4,122 9.22 38.0K 24,777 D ↗
2025-07-01 Sequeira Ramona Director A-Award A Phantom Stock 21,891 0.00 — 21,891 D ↗
2025-06-13 Whiteford Grace Puma Director A-Award A Phantom Stock 23,904 0.00 — 62,703 D ↗
2025-06-13 Sharp Shalini Director A-Award A Phantom Stock 23,904 0.00 — 63,054 D ↗
2025-06-13 Patton Cynthia M Director A-Award A Phantom Stock 23,904 0.00 — 62,703 D ↗
2025-06-13 Ozuah Philip Director A-Award A Phantom Stock 23,904 0.00 — 62,703 D ↗
2025-06-13 Leone Deborah R Director A-Award A Phantom Stock 23,904 0.00 — 62,703 D ↗
2025-06-13 LAZARUS ROCHELLE B Director A-Award A Phantom Stock 23,904 0.00 — 62,703 D ↗
2025-06-13 Gayle Helene D Director A-Award A Phantom Stock 23,904 0.00 — 62,703 D ↗
2025-06-13 Ezekowitz Alan Director A-Award A Phantom Stock 23,904 0.00 — 62,703 D ↗
2025-06-13 ESSNER ROBERT Director A-Award A Phantom Stock 23,904 0.00 — 62,703 D ↗
2025-06-13 COX CARRIE SMITH Director A-Award A Phantom Stock 23,904 0.00 — 74,030 D ↗
2025-05-15 Holzbaur Lynette Officer — — Common Stock 0 0.00 — 10,777 D ↗
2025-05-14 COX CARRIE SMITH Director P-Purchase A Common Stock 12,469 8.07 100.6K 12,469 D ↗
2025-05-07 Falcione Aaron Officer P-Purchase A Common Stock 5,500 8.77 48.2K 62,974 D ↗
2025-05-06 Weaver Kirke Officer P-Purchase A Common Stock 8,045 9.21 74.1K 52,489 D ↗
2025-05-06 Karp Daniel Officer P-Purchase A Common Stock 3,500 8.24 28.8K 46,669 D ↗
2025-05-05 WALSH MATTHEW M Officer P-Purchase A Common Stock 11,400 8.82 100.5K 144,484 D ↗
2025-05-05 Ali Kevin Director / Officer P-Purchase A Common Stock 34,000 8.81 299.4K 282,731 D ↗
2025-03-31 Weaver Kirke Officer M-Exempt D Restricted Stock Units 6,200 0.00 — 6,200 D ↗
2025-03-31 WALSH MATTHEW M Officer F-InKind D Common Stock 5,933 14.51 86.1K 129,149 D ↗
2025-03-31 Stahler Rachel A Officer M-Exempt A Common Stock 6,555 0.00 — 78,060 D ↗
2025-03-31 Nisita Vittorio Officer A-Award A Stock Option (right to buy) 123,762 14.89 1.84M 123,762 D ↗
2025-03-31 Morrissey Joseph T. Jr. Officer M-Exempt D Restricted Stock Units 3,937 0.00 — 0 D ↗
2025-03-31 Karp Daniel Officer M-Exempt D Restricted Stock Units 4,294 0.00 — 0 D ↗
2025-03-31 Falcione Aaron Officer M-Exempt D Restricted Stock Units 3,579 0.00 — 0 D ↗
2025-03-31 DiMarco Kathryn Officer F-InKind D Common Stock 3,644 14.51 52.9K 30,327 D ↗
2025-03-31 Arjona Ferreira Juan Camilo Officer F-InKind D Common Stock 3,172 14.51 46.0K 17,380 D ↗
2025-03-31 Ali Kevin Director / Officer M-Exempt D Restricted Stock Units 21,472 0.00 — 0 D ↗
2025-03-29 Karp Daniel Officer — D Restricted Stock Units 42,553 0.00 — 0 — ↗
2025-03-29 Falcione Aaron Officer F-InKind D Common Stock 2,885 14.51 41.9K 51,517 D ↗
2025-02-20 WALSH MATTHEW M Officer A-Award A Common Stock 30,414 0.00 — 122,388 D ↗
2025-02-20 Stahler Rachel A Officer F-InKind D Common Stock 5,142 14.92 76.7K 59,081 D ↗
2025-02-20 Nisita Vittorio Officer F-InKind D Common Stock 4,211 14.92 62.8K 31,766 D ↗
2025-02-20 Morrissey Joseph T. Jr. Officer A-Award A Common Stock 2,828 0.00 — 56,434 D ↗
2025-02-20 Falcione Aaron Officer A-Award A Common Stock 2,571 0.00 — 44,113 D ↗
2025-02-20 Ali Kevin Director / Officer F-InKind D Common Stock 8,529 15.29 130.4K 199,919 D ↗
2024-11-07 Arjona Ferreira Juan Camilo Officer F-InKind D Common Stock 2,300 15.80 36.3K 11,687 D ↗
2024-09-09 Karp Daniel Officer — D Common Stock 0 0.00 — 19,362 — ↗
2024-09-03 WALSH MATTHEW M Officer A-Award A Common Stock 7,189 0.00 — 95,515 — ↗
2024-09-03 Stahler Rachel A Officer F-InKind D Common Stock 1,645 20.35 33.5K 50,186 — ↗
2024-09-03 Nisita Vittorio Officer F-InKind D Common Stock 1,231 20.35 25.1K 24,748 — ↗
2024-09-03 Morrissey Joseph T. Jr. Officer F-InKind D Common Stock 1,564 20.35 31.8K 42,868 — ↗
2024-09-03 Fiedler Susanne Officer F-InKind D Common Stock 1,145 20.35 23.3K 53,113 — ↗
2024-09-03 Falcione Aaron Officer F-InKind D Common Stock 1,350 20.35 27.5K 32,659 — ↗
2024-09-03 DiMarco Kathryn Officer F-InKind D Common Stock 1,231 20.35 25.1K 23,333 — ↗
2024-09-03 Ali Kevin Director / Officer F-InKind D Common Stock 11,927 20.35 242.7K 144,888 — ↗
2024-08-11 Arjona Ferreira Juan Camilo Officer M-Exempt D Restricted Stock Units 11,519 0.00 — 23,038 — ↗
2024-06-07 Whiteford Grace Puma Director A-Award A Phantom Stock 9,639 0.00 — 36,455 — ↗
2024-06-07 Sharp Shalini Director A-Award A Phantom Stock 9,639 0.00 — 36,784 — ↗
2024-06-07 Patton Cynthia M Director A-Award A Phantom Stock 9,639 0.00 — 36,455 — ↗
2024-06-07 Ozuah Philip Director A-Award A Phantom Stock 9,639 0.00 — 36,455 — ↗
2024-06-07 McGarry Martha E Director A-Award A Phantom Stock 9,639 0.00 — 36,455 — ↗
2024-06-07 Leone Deborah R Director A-Award A Phantom Stock 9,639 0.00 — 36,455 — ↗
2024-06-07 LAZARUS ROCHELLE B Director A-Award A Phantom Stock 9,639 0.00 — 36,455 — ↗
2024-06-07 Gayle Helene D Director A-Award A Phantom Stock 9,639 0.00 — 36,455 — ↗
2024-06-07 Ezekowitz Alan Director A-Award A Phantom Stock 9,639 0.00 — 36,455 — ↗
2024-06-07 ESSNER ROBERT Director A-Award A Phantom Stock 9,639 0.00 — 36,455 — ↗
2024-06-07 COX CARRIE SMITH Director A-Award A Phantom Stock 9,639 0.00 — 47,060 — ↗
2024-05-04 Weaver Kirke Officer F-InKind D Common Stock 356 19.61 7.0K 29,160 — ↗
2024-05-04 WALSH MATTHEW M Officer F-InKind D Common Stock 4,093 19.61 80.3K 88,326 — ↗
2024-05-04 Stahler Rachel A Officer M-Exempt A Common Stock 3,049 0.00 — 49,282 — ↗
2024-05-04 Nisita Vittorio Officer M-Exempt D Restricted Stock Units 2,078 0.00 — 0 — ↗
2024-05-04 Morrissey Joseph T. Jr. Officer M-Exempt A Common Stock 3,604 0.00 — 42,406 — ↗
2024-05-04 Fiedler Susanne Officer M-Exempt A Common Stock 4,989 0.00 — 52,253 — ↗
2024-05-04 Falcione Aaron Officer M-Exempt A Common Stock 2,770 0.00 — 31,364 — ↗
2024-05-04 DiMarco Kathryn Officer M-Exempt D Restricted Stock Units 1,248 0.00 — 0 — ↗
2024-05-04 Ali Kevin Director / Officer M-Exempt D Restricted Stock Units 22,161 0.00 — 0 — ↗
2024-03-31 Weaver Kirke Officer M-Exempt A Common Stock 3,125 0.00 — 29,159 — ↗
2024-03-31 WALSH MATTHEW M Officer M-Exempt A Common Stock 12,046 0.00 — 90,042 — ↗
2024-03-31 Stahler Rachel A Officer M-Exempt D Restricted Stock Units 3,578 0.00 — 3,579 — ↗
2024-03-31 Nisita Vittorio Officer M-Exempt D Restricted Stock Units 4,606 0.00 — 9,212 — ↗
2024-03-31 Morrissey Joseph T. Jr. Officer F-InKind D Common Stock 2,328 18.80 43.8K 38,802 — ↗
2024-03-31 Fiedler Susanne Officer M-Exempt A Common Stock 7,794 0.00 — 49,747 — ↗
2024-03-31 Falcione Aaron Officer M-Exempt A Common Stock 6,731 0.00 — 30,900 — ↗
2024-03-31 DiMarco Kathryn Officer M-Exempt A Common Stock 8,503 0.00 — 23,063 — ↗
2024-03-31 Ali Kevin Director / Officer F-InKind D Common Stock 21,553 18.80 405.2K 125,343 — ↗
2024-03-29 Weaver Kirke Officer A-Award A Restricted Stock Units 23,271 0.00 — 23,271 — ↗
2024-03-29 WALSH MATTHEW M Officer A-Award A Restricted Stock Units 45,212 0.00 — 45,212 — ↗
2024-03-29 Stahler Rachel A Officer A-Award A Restricted Stock Units 24,601 0.00 — 24,601 — ↗
2024-03-29 Nisita Vittorio Officer A-Award A Restricted Stock Units 17,287 0.00 — 17,287 — ↗
2024-03-29 Morrissey Joseph T. Jr. Officer A-Award A Restricted Stock Units 29,255 0.00 — 29,255 — ↗
2024-03-29 Fiedler Susanne Officer A-Award A Stock Option (right to buy) 119,825 18.80 2.25M 119,825 — ↗
2024-03-29 Falcione Aaron Officer A-Award A Restricted Stock Units 25,265 0.00 — 25,265 — ↗
2024-03-29 DiMarco Kathryn Officer A-Award A Restricted Stock Units 31,914 0.00 — 31,914 — ↗
2024-03-29 Arjona Ferreira Juan Camilo Officer A-Award A Stock Option (right to buy) 108,932 18.80 2.05M 108,932 — ↗
2024-03-29 Ali Kevin Director / Officer A-Award A Restricted Stock Units 146,276 0.00 — 146,276 — ↗
2024-02-28 Weaver Kirke Officer M-Exempt A Common Stock 4,957 0.00 — 20,138 — ↗
2024-02-28 WALSH MATTHEW M Officer M-Exempt A Common Stock 33,044 0.00 — 85,455 — ↗
2024-02-28 Stahler Rachel A Officer M-Exempt A Common Stock 12,117 0.00 — 43,898 — ↗
2024-02-28 Nisita Vittorio Officer M-Exempt D Restricted Stock Units 8,261 0.00 — 0 — ↗
2024-02-28 Morrissey Joseph T. Jr. Officer M-Exempt D Restricted Stock Units 14,319 0.00 — 0 — ↗
2024-02-28 Fiedler Susanne Officer M-Exempt D Restricted Stock Units 19,827 0.00 — 0 — ↗
2024-02-28 Falcione Aaron Officer M-Exempt D Restricted Stock Units 11,015 0.00 — 0 — ↗
2024-02-28 DiMarco Kathryn Officer F-InKind D Common Stock 1,868 18.04 33.7K 11,737 — ↗
2024-02-28 Ali Kevin Director / Officer M-Exempt D Restricted Stock Units 88,121 0.00 — 0 — ↗
2024-02-22 Weaver Kirke Officer P-Purchase A Common Stock 2,720 18.36 49.9K 15,181 — ↗
2024-02-09 DiMarco Kathryn Officer M-Exempt A Common Stock 1,871 0.00 — 9,388 — ↗
2024-01-01 Arjona Ferreira Juan Camilo Officer — D Common Stock 0 0.00 — 13 — ↗
2023-08-05 WALSH MATTHEW M Officer M-Exempt D Restricted Stock Units 22,347 0.00 — 0 — ↗
2023-08-05 Stahler Rachel A Officer M-Exempt D Restricted Stock Units 12,895 0.00 — 0 — ↗
2023-06-09 Whiteford Grace Puma Director A-Award A Phantom Stock 10,086 0.00 — 25,285 — ↗
2023-06-09 Sharp Shalini Director A-Award A Phantom Stock 10,086 0.00 — 25,594 — ↗
2023-06-09 Patton Cynthia M Director A-Award A Phantom Stock 10,086 0.00 — 25,285 — ↗
2023-06-09 Ozuah Philip Director A-Award A Phantom Stock 10,086 0.00 — 25,285 — ↗
2023-06-09 McGarry Martha E Director A-Award A Phantom Stock 10,086 0.00 — 25,285 — ↗
2023-06-09 Leone Deborah R Director A-Award A Phantom Stock 10,086 0.00 — 25,285 — ↗
2023-06-09 LAZARUS ROCHELLE B Director A-Award A Phantom Stock 10,086 0.00 — 25,285 — ↗
2023-06-09 Gayle Helene D Director A-Award A Phantom Stock 10,086 0.00 — 25,285 — ↗
2023-06-09 Francisco Ma. Fatima Director A-Award A Phantom Stock 10,086 0.00 — 25,285 — ↗
2023-06-09 Ezekowitz Alan Director A-Award A Phantom Stock 10,086 0.00 — 25,285 — ↗
2023-06-09 ESSNER ROBERT Director A-Award A Phantom Stock 10,086 0.00 — 25,285 — ↗
2023-06-09 COX CARRIE SMITH Director A-Award A Phantom Stock 10,086 0.00 — 35,232 — ↗
2023-05-04 Weaver Kirke Officer M-Exempt A Common Stock 1,246 0.00 — 12,816 — ↗
2023-05-04 WALSH MATTHEW M Officer M-Exempt A Common Stock 8,310 0.00 — 45,113 — ↗
2023-05-04 Stahler Rachel A Officer F-InKind D Common Stock 1,044 24.24 25.3K 23,304 — ↗
2023-05-04 Ritter Geralyn S Officer F-InKind D Common Stock 665 24.24 16.1K 10,755 — ↗
2023-05-04 Nisita Vittorio Officer M-Exempt D Restricted Stock Units 2,077 0.00 — 2,078 — ↗
2023-05-04 Morrissey Joseph T. Jr. Officer F-InKind D Common Stock 1,162 24.24 28.2K 21,016 — ↗
2023-05-04 Milligan Sandra Officer M-Exempt A Common Stock 4,984 0.00 — 30,767 — ↗
2023-05-04 Fiedler Susanne Officer M-Exempt A Common Stock 4,984 0.00 — 26,779 — ↗
2023-05-04 Falcione Aaron Officer F-InKind D Common Stock 949 24.24 23.0K 14,762 — ↗
2023-05-04 DiMarco Kathryn Officer M-Exempt A Common Stock 1,246 0.00 — 7,944 — ↗
2023-05-04 Ali Kevin Director / Officer M-Exempt D Restricted Stock Units 22,158 0.00 — 22,161 — ↗
2023-05-01 Weaver Kirke Officer M-Exempt D Restricted stock units 1,099 0.00 — 0 — ↗
2023-05-01 Ritter Geralyn S Officer M-Exempt D Restricted Stock Units 977 0.00 — 0 — ↗
2023-05-01 Nisita Vittorio Officer M-Exempt D Restricted Stock Units 815 0.00 — 0 — ↗
2023-05-01 Morrissey Joseph T. Jr. Officer M-Exempt D Restricted Stock Units 1,490 0.00 — 0 — ↗
2023-05-01 Milligan Sandra Officer F-InKind D Common Stock 826 24.63 20.3K 25,783 — ↗
2023-05-01 Fiedler Susanne Officer M-Exempt A Common Stock 2,168 0.00 — 22,814 — ↗
2023-05-01 Falcione Aaron Officer M-Exempt A Common Stock 1,221 0.00 — 13,360 — ↗
2023-05-01 Ali Kevin Director / Officer M-Exempt A Common Stock 2,711 0.00 — 42,206 — ↗
2023-03-31 Weaver Kirke Officer A-Award A Stock Option (right to buy) 66,793 23.52 1.57M 66,793 — ↗
2023-03-31 WALSH MATTHEW M Officer A-Award A Stock Option (right to buy) 129,770 23.52 3.05M 129,770 — ↗
2023-03-31 Stahler Rachel A Officer M-Exempt A Common Stock 3,578 0.00 — 22,528 — ↗
2023-03-31 Ritter Geralyn S Officer M-Exempt D Restricted Stock Units 1,908 0.00 — 3,817 — ↗
2023-03-31 Nisita Vittorio Officer F-InKind D Common Stock 981 23.09 22.7K 8,986 — ↗
2023-03-31 Morrissey Joseph T. Jr. Officer F-InKind D Common Stock 1,122 23.09 25.9K 17,514 — ↗
2023-03-31 Milligan Sandra Officer A-Award A Stock Option (right to buy) 104,961 23.52 2.47M 104,961 — ↗
2023-03-31 Fiedler Susanne Officer A-Award A Stock Option (right to buy) 83,969 23.52 1.97M 83,969 — ↗
2023-03-31 Falcione Aaron Officer A-Award A Restricted Stock Units 20,195 0.00 — 20,195 — ↗
2023-03-31 DiMarco Kathryn Officer M-Exempt A Common Stock 4,294 0.00 — 8,169 — ↗
2023-03-31 Ali Kevin Director / Officer A-Award A Stock Option (right to buy) 419,847 23.52 9.87M 419,847 — ↗
2023-02-28 Weaver Kirke Officer M-Exempt D Restricted Stock Units 4,616 0.00 — 0 — ↗
2023-02-28 Ritter Geralyn S Officer M-Exempt D Restricted Stock Units 4,102 0.00 — 0 — ↗
2023-02-28 Nisita Vittorio Officer M-Exempt D Restricted Stock Units 3,419 0.00 — 0 — ↗
2023-02-28 Morrissey Joseph T. Jr. Officer M-Exempt D Restricted Stock Units 6,266 0.00 — 0 — ↗
2023-02-28 Milligan Sandra Officer M-Exempt D Restricted Stock Units 7,976 0.00 — 0 — ↗
2023-02-28 Fiedler Susanne Officer M-Exempt D Restricted Stock Units 9,116 0.00 — 0 — ↗
2023-02-28 Falcione Aaron Officer M-Exempt D Restricted Stock Units 5,125 0.00 — 0 — ↗
2023-02-28 Ali Kevin Director / Officer M-Exempt D Restricted Stock Units 11,393 0.00 — 0 — ↗
2023-02-09 DiMarco Kathryn Officer M-Exempt A Common Stock 1,869 0.00 — 4,615 — ↗
2023-01-01 Weaver Kirke Officer — D Common Stock 0 0.00 — 2,296 — ↗
2022-08-05 WALSH MATTHEW M Officer M-Exempt A Common Stock 22,343 0.00 — 42,496 — ↗
2022-08-05 Stahler Rachel A Officer M-Exempt A Common Stock 12,890 0.00 — 23,366 — ↗
2022-06-10 Whiteford Grace Puma Director A-Award A Phantom Stock 5,640 35.46 200.0K 14,638 — ↗
2022-06-10 Sharp Shalini Director A-Award A Phantom Stock 5,640 35.46 200.0K 14,935 — ↗
2022-06-10 Patton Cynthia M Director A-Award A Phantom Stock 5,640 0.00 — 14,638 — ↗
2022-06-10 Ozuah Phillip Director A-Award A Phantom Stock 5,640 35.46 200.0K 14,638 — ↗
2022-06-10 McGarry Martha E Director A-Award A Phantom Stock 5,640 35.46 200.0K 14,638 — ↗
2022-06-10 Leone Deborah R Director A-Award A Phantom Stock 5,640 35.46 200.0K 14,638 — ↗
2022-06-10 LAZARUS ROCHELLE B Director A-Award A Phantom Stock 5,640 35.46 200.0K 14,638 — ↗
2022-06-10 Gayle Helene D Director A-Award A Phantom Stock 5,640 35.46 200.0K 14,638 — ↗
2022-06-10 Francisco Ma. Fatima Director A-Award A Phantom Stock 5,640 35.46 200.0K 14,638 — ↗
2022-06-10 Ezekowitz Alan Director A-Award A Phantom Stock 5,640 35.46 200.0K 14,638 — ↗
2022-06-10 ESSNER ROBERT Director A-Award A Phantom Stock 5,640 0.00 — 14,638 — ↗

Executive team

Top executives
EBIT / Employee
92.9K
Shares Outstanding
262.60M

Executive compensation

Executive compensation (annual)
# Year ⇅ Executive ⇅ Salary ⇅ Bonus Stock award ⇅ Option award Incentive Other Total ⇅ % Stock-
based ⇅		 Filing
1 2025 Kevin Ali Former Chief Executive Officer 1.09M — 10.25M 3.25M — 1.22M 15.81M 85.38% ↗
2 2025 Joseph Morrissey Interim Chief Executive Officer 819.2K — 3.37M 750.0K 602.4K 235.4K 5.77M 71.30% ↗
3 2025 Matthew Walsh EVP and Chief Financial Officer 919.2K — 3.04M 962.5K 532.8K 235.5K 5.69M 70.32% ↗
4 2025 Juan Camilo Arjona Ferreira, M.D. EVP and Head of R&D and Chief Medical Officer 734.6K — 1.89M 600.0K 437.8K 157.5K 3.82M 65.21% ↗
5 2025 Rachel Stahler EVP and Chief Digital 706.9K — 1.73M 550.0K 411.8K 147.9K 3.55M 64.33% ↗
6 2025 Kirke Weaver EVP, General Counsel and Corporate Secretary 676.9K — 1.73M 550.0K 394.6K 186.6K 3.54M 64.49% ↗
7 2024 Kevin Ali Chief Executive Officer 1.25M — 9.16M 2.75M 2.51M 1.44M 17.12M 69.58% ↗
8 2024 Kevin Ali Former Chief Executive Officer 1.25M — 9.16M 2.75M 2.51M 1.44M 17.12M 69.58% ↗
9 2024 Matthew Walsh EVP and Chief Financial Officer 900.0K — 2.83M 850.0K 964.8K 200.7K 5.75M 64.06% ↗
10 2024 Susanne Fiedler Former EVP and Chief Commercial Officer 738.3K — 1.83M 550.0K 791.5K 285.4K 4.20M 56.75% ↗
11 2024 Joseph Morrissey Interim Chief Executive Officer 750.0K — 1.83M 550.0K 804.0K 193.8K 4.13M 57.68% ↗
12 2024 Joseph Morrissey EVP and Head of Manufacturing and Supply 750.0K — 1.83M 550.0K 804.0K 193.8K 4.13M 57.68% ↗
13 2024 Juan Camilo Arjona Ferreira, M.D. EVP and Head of R&D and Chief Medical Officer 650.0K — 1.67M 500.0K 696.8K 87.4K 3.60M 60.16% ↗
14 2024 Kirke Weaver EVP, General Counsel and Corporate Secretary 650.0K 210.7K 1.46M 437.5K 609.7K 158.9K 3.52M 53.77% ↗
15 2023 Kevin Ali Chief Executive Officer 1.24M — 8.26M 2.75M 1.84M 740.5K 14.83M 74.23% ↗
16 2023 Kevin Ali Former Chief Executive Officer 1.24M — 8.26M 2.75M 1.84M 740.5K 14.83M 74.23% ↗
17 2023 Matthew Walsh EVP and Chief Financial Officer 890.1K — 2.55M 849.8K 705.6K 214.1K 5.21M 65.28% ↗
18 2023 Sandra Milligan, M.D. Former EVP and Head of Research and Development 788.5K — 2.07M 687.3K 627.2K 188.6K 4.36M 63.18% ↗
19 2023 Susanne Fiedler Former EVP and Chief Commercial Officer 726.7K — 1.65M 549.9K 576.2K 331.5K 3.84M 57.40% ↗
20 2023 Susanne Fiedler EVP and Chief Commercial Officer 726.7K — 1.65M 549.9K 576.2K 331.5K 3.84M 57.40% ↗
21 2023 Joseph Morrissey Interim Chief Executive Officer 740.8K — 1.65M 549.9K 588.0K 206.2K 3.74M 58.92% ↗
22 2023 Joseph Morrissey EVP and Head of Manufacturing and Supply 740.8K — 1.65M 549.9K 588.0K 206.2K 3.74M 58.92% ↗
23 2023 Kirke Weaver EVP, General Counsel and Corporate Secretary 650.0K 210.7K 1.31M 437.4K 445.9K 134.6K 3.19M 54.86% ↗
24 2022 Kevin Ali Chief Executive Officer 1.20M — 7.35M 2.25M 1.84M 896.5K 13.53M 70.90% ↗
25 2022 Matthew Walsh EVP and Chief Financial Officer 849.4K — 2.65M 812.5K 822.7K 169.6K 5.31M 65.29% ↗
26 2022 Sandra Milligan, M.D. EVP and Head of Research and Development 731.4K — 2.43M 625.0K 720.0K 152.9K 4.66M 65.54% ↗
27 2022 Sandra Milligan, M.D. Former EVP and Head of Research and Development 731.4K — 2.04M 625.0K 720.0K 152.9K 4.27M 62.42% ↗
28 2022 Susanne Fiedler EVP and Chief Commercial Officer 686.3K — 1.63M 500.0K 664.5K 173.0K 3.66M 58.32% ↗
29 2022 Susanne Fiedler Former EVP and Chief Commercial Officer 686.3K — 1.63M 500.0K 664.5K 173.0K 3.66M 58.32% ↗
30 2022 Joseph Morrissey EVP and Head of Manufacturing and Supply 688.8K — 1.35M 412.5K 681.6K 165.7K 3.30M 53.38% ↗
31 2021 Kevin Ali Chief Executive Officer 1.13M — 7.75M 7.66M 1.49M 518.8K 18.55M 83.07% ↗
32 2021 Matthew Walsh EVP and Chief Financial Officer 825.1K — 2.81M 2.38M 692.2K 53.3K 6.76M 76.76% ↗
33 2021 Susanne Fiedler EVP and Chief Commercial Officer 672.9K — 1.62M 2.01M 569.4K 444.4K 5.32M 68.27% ↗
34 2021 Sandra Milligan, M.D. Former EVP and Head of Research and Development 670.4K — 1.62M 2.10M 492.1K 43.1K 4.93M 75.56% ↗
35 2021 Deborah H. Telman EVP and General Counsel and Corporate Secretary 670.4K — 1.47M 1.15M 492.1K 331.3K 4.11M 63.68% ↗
36 2021 Sandra Milligan, M.D. EVP and Head of Research and Development 670.4K — 1.61M 1.26M 492.1K 43.1K 4.08M 70.42% ↗
37 2021 Sandra Milligan, M.D. EVP and Head of Research & Development 670.4K — 1.61M 1.26M 492.1K 43.1K 4.08M 70.42% ↗
CEO compensation breakdown

Proxy statements

Proxy statements (DEF 14A)
Filing date Form type Filing
2026-04-30 DEFA14A ↗
2026-04-30 DEFA14A ↗
2026-04-27 DEFA14A ↗
2026-04-27 DEFA14A ↗
2026-04-27 DEFA14A ↗
2026-04-27 DEFA14A ↗
2026-04-24 DEFA14A ↗
2026-04-24 DEF 14A ↗
2025-04-25 DEFA14A ↗
2025-04-25 DEF 14A ↗

Recent SEC filings

Recent SEC filings
Filing date Form type Filing
2026-05-07 4/A ↗
2026-05-07 4 ↗
2026-05-04 10-Q ↗
2026-04-30 SC 13G ↗
2026-04-30 DEFA14A ↗
2026-04-30 DEFA14A ↗
2026-04-30 8-K ↗
2026-04-29 SC 13G ↗
2026-04-27 DEFA14A ↗
2026-04-27 DEFA14A ↗

Executive team

NameTitleCompensationGender
Matthew Walsh Executive Vice President & Chief Financial Officer 2M male
Joseph T. Morrissey Jr. Interim Chief Executive Officer 2M male
Juan Camilo Arjona Ferreira Executive Vice President, Head of Research & Development and Chief Medical Officer 1M —
Rachel A. Stahler Executive VP, Chief Information Officer and Chief Digital & Growth Officer 1M female
Kirke Weaver Executive Vice President, General Counsel & Corporate Secretary 1M male
Carrie Smith Cox Executive Chair of the Board 220.6K female
Aaron Falcione Executive Vice President & Chief Human Resources Officer — male
Vittorio Nisita Executive Vice President & Head of Enterprise Services and Solutions — male
Daniel Karp Chief Strategy Officer & Head of Corporate Development — male
Jennifer Halchak Head of Investor Relations — female
Juliana Papa Drinane Interim Head of Manufacturing & Supply — female
Mike Casia Interim Head of U.S. Commercial & Government Affairs — male
ESG Rating
B
DRUG MANUFACTURERS - GENERAL
2025
E (Environmental)
68.2 / 68.7
Company / Sector avg.
S (Social)
61.7 / 66.7
Company / Sector avg.
G (Governance)
67.4 / 67.9
Company / Sector avg.
ESG Total
65.8 / 67.7
Company / Sector avg.
ESG Score History DRUG MANUFACTURERS - GENERAL
Benchmark vs Sector
Political Trading Activity (25M)
Senate Trading Activity
Transaction Date Disclosed Senator State Owner Type Amount Link
2025-10-07 2025-11-24 Gary Peters MI Self Sale $1,001 - $15,000 ↗
2025-07-10 2025-11-24 Gary Peters MI Self Sale (Full) $1,001 - $15,000 ↗
2021-06-28 2021-07-09 John W. Hickenlooper CO Self Sale (Full) $1,001 - $15,000 ↗
House Trading Activity
Transaction Date Disclosed Representative District Owner Type Amount Link
2023-11-03 2023-12-06 Ro Khanna CA17 — Sale $1,001 - $15,000 ↗
2023-10-02 2023-11-08 Ro Khanna CA17 — Purchase $1,001 - $15,000 ↗
2023-07-28 2023-08-07 Ro Khanna CA17 — Sale $1,001 - $15,000 ↗
2023-06-29 2023-07-11 Ro Khanna CA17 Spouse Purchase $1,001 - $15,000 ↗
2023-05-19 2023-06-12 Ro Khanna CA17 Spouse Sale $1,001 - $15,000 ↗
2023-04-25 2023-05-08 Ro Khanna CA17 — Purchase $1,001 - $15,000 ↗
2023-03-14 2023-04-07 Ro Khanna CA17 Spouse Purchase $1,001 - $15,000 ↗
2022-09-22 2022-10-13 Michael McCaul TX10 Spouse Sale $15,001 - $50,000 ↗
2022-09-22 2022-10-13 Michael McCaul TX10 — Sale $1,001 - $15,000 ↗
2022-09-21 2022-10-13 Michael McCaul TX10 — Sale $15,001 - $50,000 ↗
2022-09-21 2022-10-13 Michael McCaul TX10 Spouse Sale $100,001 - $250,000 ↗
2022-09-15 2022-10-13 Michael McCaul TX10 Spouse Sale $15,001 - $50,000 ↗
2022-09-15 2022-10-13 Michael McCaul TX10 — Sale $1,001 - $15,000 ↗
2022-09-14 2022-10-13 Michael McCaul TX10 Spouse Sale $50,001 - $100,000 ↗
2022-09-14 2022-10-13 Michael McCaul TX10 — Sale $15,001 - $50,000 ↗
2022-09-13 2022-10-13 Michael McCaul TX10 Spouse Sale $50,001 - $100,000 ↗
2022-09-13 2022-10-13 Michael McCaul TX10 — Sale $15,001 - $50,000 ↗
2022-09-09 2022-10-13 Michael McCaul TX10 Spouse Sale $15,001 - $50,000 ↗
2022-09-09 2022-10-13 Michael McCaul TX10 — Sale $1,001 - $15,000 ↗
2022-08-25 2022-09-19 Michael McCaul TX10 Spouse Sale $50,001 - $100,000 ↗
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion

Share your view on this stock and instantly see how the community has voted over the last 6 months.

These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

Dividend yield history

Dividend history

Earnings history

Earnings reports

Stock splits

Related companies

Largest companies in Drug Manufacturers - General